Latest news with #PrivateSecuritiesLitigationActof1995
Business Wire
29-05-2025
- Business
- Business Wire
Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price
CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO) ('Cardio Diagnostics' or the 'Company'), a pioneer in AI-powered precision cardiovascular medicine, today announced that on May 28, 2025, it received a notification letter (the 'Notification Letter') from the Listing Qualifications Department of The Nasdaq Stock Market LLC ('Nasdaq') notifying the Company that it had regained compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rule 5550(a)(2) ('Minimum Bid Requirement') for continued listing on The Nasdaq Capital Market. This was disclosed in the Company's Current Report on Form 8-K filed on May 28, 2025. The Nasdaq staff made this determination of compliance after the closing bid price of the Company's common stock traded above $1.00 per share from May 13, 2025, the date immediately following the Company's 1:30 reverse stock split having gone effective, through May 27, 2025. Accordingly, Nasdaq determined that the Company has regained compliance with Nasdaq's Minimum Bid Requirement, and that Nasdaq considered the matter closed. About Cardio Diagnostics Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine ('Core Technology') for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For more information, please visit Forward-Looking Statements Certain statements and information included in this press release constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases 'will', 'will likely result,' 'expected to,' 'will continue,' 'anticipated,' 'estimate,' 'projected,' 'intend,' 'goal,' or similar expressions are intended to identify 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, and dependence on results as discussed in the Annual Report on Form 10-K for the period ended December 31, 2024, under the heading 'Risk Factors' in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
Yahoo
22-05-2025
- Business
- Yahoo
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR
HOUSTON, May 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm to replace CBIZ CPAs ("CBIZ"), effective May 15, 2025. The change of the Company's independent auditor was made after careful consideration and an evaluation process and was approved by the Audit Committee and the Board of Directors of the Company. The decision to change auditors was not as a result of any disagreement between the Company and CBIZ on any matter of accounting principles or practices, financial statement disclosure, auditing scope or procedures. The Company is working closely with CBIZ and Grant Thornton to ensure a seamless transition. "Building on our great momentum and steadily increasing market cap, and also as part of the Company's commitment to best corporate governance practices, our Board of Directors believed it was a good time to change auditors. We would like to extend our gratitude to CBIZ for their expertise and quality audit services provided to the Company over many years," stated Jon Bates, Chief Financial Officer of Nutex Health. About Nutex Health Inc. Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Forward-Looking Statements Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2024, under the heading "Risk Factors" in Part II, Item IA thereof, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release. View original content: SOURCE Nutex Health, Inc.
Yahoo
16-05-2025
- Business
- Yahoo
Peoples Bancorp Announces Cash Dividend
NEWTON, NC / / May 16, 2025 / The Board of Directors of Peoples Bancorp of North Carolina, Inc., Newton, NC (Nasdaq:PEBK) declared the Company's regular cash dividend for the second quarter of 2025 in the amount of $0.20 per share. The second quarter cash dividend will be paid on June 13, 2025 to shareholders of record on June 3, 2025. Shareholders are encouraged to enroll in the Company's Dividend Reinvestment and Stock Purchase Plan. For details, contact Krissy Price at (828) 464-5620 or (800) 948-7195 or you may email any questions to our transfer agent, Broadridge Corporate Issuer Solutions, Inc. at shareholder@ Peoples Bank, the wholly-owned subsidiary of Peoples Bancorp of North Carolina, Inc. operates 16 banking offices entirely in North Carolina, with offices in Catawba, Alexander, Lincoln, Mecklenburg, Iredell and Wake Counties. The Bank also operates loan production offices in Lincoln, Mecklenburg, Rowan, and Forsyth Counties. The Company's common stock is publicly traded and is quoted on the Nasdaq Global Market under the symbol "PEBK." Statements made in this press release, other than those concerning historical information, should be considered forward-looking statements pursuant to the safe harbor provisions of the Securities Exchange Act of 1934 and the Private Securities Litigation Act of 1995. These forward-looking statements are based on information currently available to management and are subject to various risks and uncertainties, including but not limited to those described in Peoples Bancorp of North Carolina, Inc.'s annual report on Form 10-K for the year ended December 31, 2024, under "General Description of Business" and otherwise in the Company's reports and filings. END SOURCE: Peoples Bancorp of North Carolina, Inc. View the original press release on ACCESS Newswire
Globe and Mail
12-03-2025
- Entertainment
- Globe and Mail
Big Screen Entertainment Group Enters the $500 Billion Beauty Industry
LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) -- Big Screen Entertainment Group (OTC: BSEG) is making a bold expansion into the booming beauty industry—an ever-growing global market projected to exceed $700 billion by 2028. The Los Angeles-based film and television company has completed filming on the pilot episode of a beauty-focused TV show, seamlessly integrating a new line of cutting-edge beauty products backed by top industry experts. This venture marks a strategic expansion for Big Screen, leveraging its entertainment expertise to enter one of the most profitable consumer sectors. While the name of the series and details of the product line remain confidential for now, audiences can expect a blend of Hollywood glamour and transformative beauty experiences featuring a lineup of well-known faces. Among them is celebrated actress Kelli Maroney (Fast Times at Ridgemont High, Night of the Comet), who joins the show in an exciting role. Also starring as the beauty expert is Michelle Guo, owner of MG Aesthetics and Mrs. Asian International. The show is directed by BSEG's Catherine Taylor, and produced by Big Screen CEO, Kimberley Kates, who expressed enthusiasm about the company's latest endeavor: 'The beauty industry is a natural fit for Big Screen's expansion. With a loyal audience, high engagement, and a global demand for innovation, this is an exciting new chapter for us. We're merging entertainment with an industry that thrives on storytelling, transformation, and aspirational lifestyle—making this the perfect synergy for success.' The beauty sector has evolved into one of the most lucrative industries worldwide, driven by digital influencers, social commerce, and the increasing demand for premium self-care products. Beauty now accounts for 20% of all e-commerce sales, offering an unprecedented growth opportunity for companies positioned at the intersection of media and consumer engagement. This latest move from Big Screen Entertainment Group reinforces its commitment to expanding beyond traditional entertainment, building strong revenue streams in high-growth markets. More details on this exciting new venture will be unveiled in the coming months. About BSEG Big Screen Entertainment Group (OTC: BSEG) is a cutting-edge film and television production company with a diverse portfolio spanning entertainment, technology, and consumer products. With decades of experience in creating and distributing compelling content, Big Screen is now applying its expertise to high-growth industries, bridging the worlds of media and commerce in innovative ways. Forward-Looking Statement: A number of statements contained in the press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including timely development, and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions and the ability to secure additional sources of financing. When used in this press release, words such as 'could,' 'plan,' 'estimate,' 'expect,' 'intend,' 'may,' 'potential,' 'should,' and similar expressions are forward-looking statements.
